3.0
13. Nov. 2012
Aktueller Mitarbeiter, mehr als 5 Jahre
Empfehlen
CEO-Befürwortung
Geschäftsprognose
Pros
+ Fully integrated biotech, meaning that you can move between jobs in sales, research, development, manufacturing and in support functions -- all in the same company + Promising drug pipeline
Kontras
Many of the perqs that were omnipresent during the Avastin years are slowly dropping away, as Roche takes a firmer hand managing the compensation of the US (Genentech) staff. This is least apparent in Research; most apparent in the support functions (IT, HR, Legal, etc.). Be very wary of putting too much stock in the 'Best Places to Work' wins in 2008-2011 -- much has changed since then.